Ning Wang

West China Biopharmaceutical Research Institute, West China Hospital, Sichuan University, Chengdu, China.

2 papers in the library · 30 citations · publishing 2021-2026

Papers

A Bibliometric and Visualization Analysis of Mindfulness and Meditation Research from 1900 to 2021

International Journal of Environmental Research and Public Health December 13, 2021 Yuzheng Wang, Lingqiu Liao, Xiaoxiao Lin et al. 30 citations

From 1900 to 2021, research on meditation—especially mindfulness meditation—grew from a single article in 1963 to 19,752 publications. The United States leads in collaboration, output, and citations. The journal Mindfulness published the most articles, and the most cited paper is Brown and Ryan's work on mindfulness and psychological well-being. Frequently studied topics include mindfulness, meditation, depression, intervention, stress reduction, stress, and anxiety. Before 2010, research focused on hypertension, cancer, and generalized anxiety disorder; after 2010, interest shifted to meta-analysis, attention, self-assessment, and mindfulness-based interventions. These results map the field's development and guide future research.

DOI: 10.3390/ijerph182413150 Mindfulness Meditation Anxiety Timeline +10

Esketamine ameliorates depression-like behavior in mice via modulation of the NRG1-ErbB4 pathway.

Frontiers in psychiatry January 1, 2026 Hang Yu, Yuqiong Zhu, Jie Wang et al.

In a mouse model of depression induced by chronic social defeat stress, susceptible mice showed reduced social interaction, lower sucrose preference, decreased NRG1 protein expression in the prefrontal cortex, and increased immobility time compared to controls. A subanesthetic dose of esketamine increased NRG1 expression in the prefrontal cortex within 30 minutes and improved social interaction and reduced immobility at both 30 minutes and 24 hours post-injection. No significant changes were observed in GAD67 or ErbB4 expression. Esketamine may rapidly improve depressive-like behavior by regulating the NRG1-ErbB4 signaling pathway.

DOI: 10.3389/fpsyt.2026.1722336 Full text Esketamine Erbb4 Nrg1 Depression disorder